Top Companies in the Industrial Enzymes Market | Growth rate, Insights, Market Outlook by VMR
Industrial Enzymes Market to Reach Valuation of 9,276.34 USD Million by 2028; Increasing Demand for Bioethanol to Flourish the Market
Coralia.Joe
Market Overview:
The Global Industrial Enzymes market is valued at 6,429.50 USD Million in 2021 and is projected to reach a value of 9,276.34 USD Million by 2028 at a CAGR of 6.30% over the forecast period. Enzymes are biocatalysts that speed up different biochemical reactions. Enzymes are useful biocatalysts in a variety of industrial and chemical processes in the present scenario. They play an important role in chemical engineering, food technology, and farming. The use of enzymes minimizes costs, reduces the production time, and improves the quality of the reaction of the substrate. Enzymes are commonly used in the detergent sector for the removal of cloth stains. In addition, they are used in a variety of processes like baking or brewing in the food and beverage industry. Moreover, enzymes are also used for drug formulation in the pharmaceutical industry.
The rising need for effective cosmetics & pharmaceuticals products and surging demand for functional food & beverages are the factors driving the global enzymes market. Moreover, increasing the application of enzyme-based techniques for the detection & treatment of various chronic diseases is likely to boost the growth of industrial enzymes market. Additionally, the increasing usage of enzymes in the food & beverage and paper & pulp industry is further expected to accelerate the industrial enzymes market growth in the upcoming years as well. However, the stringent government regulations in the developed countries are likely to restrain the industrial enzymes market growth in the near future. Conversely, the manufacturers of enzymes are largely focusing on research & development to enhance the functionalities of the enzyme. Thus, this is anticipated to offer lucrative opportunities to the global enzymes market during the forecast period.
Following are the top 9 leading companies in the Industrial Enzymes market:
|
Company Name |
Revenue in USD |
|
$13 Million |
|
$63 Million |
|
$6 Billion |
|
$2 Billion |
|
$49 Million |
|
$1 Billion |
|
$28 Million |
|
$71 Billion |
|
$51 Million |
1. Amano Enzyme
Amano Enzyme was founded 120 years ago in Japan as a pharmaceutical business, expanding into specialty enzymes in 1948 with the company’s first item malt diastase. The company has grown into one of the top enzyme manufacturers, producing enzyme solutions for any industry and every need. Originally founded in 1899, the company is the global leader in specialty enzymes and the largest manufacturer in Japan. Not only that, but the company focus on both classical (non-GMO) and modern biotechnology as part of its commitment to a happier, healthier world.
2. AB Enzyme
AB Enzymes is an industrial biotech company specializing in enzymes and their applications. The company is part of Associated British Foods and is represented worldwide. The offices are located in Brazil, China Germany, Finland, Singapore, and the USA. The products range from food-grade enzymes for baking and beverages, grains and vegetable oil seeds processing, to enzymes for animal feed and technical applications: pulp & paper, textiles, and laundry detergents. The company partners with diverse and unique customers to support them in their process optimization needs.
Agilent Technologies, Inc. is an American analytical instrumentation development and manufacturing company that offers its products and services to markets worldwide. Its global headquarters is located in Santa Clara, California. Agilent was established in 1999 as a spin-off from Hewlett-Packard. The company is listed as A (NYSE) on the New York stock exchange. The company is headquartered in Santa Clara, California, United States founded in 1999 and has generated USD 533.9 Million in 2020. The company had 13,500 employees working across major of its locations worldwide.
4. Novozyme A/S
Novozymes is the world leader in bio innovation. The company works with global partners to innovate new solutions and rethinks industries around the world. The company's industrial enzymes, microorganisms, and other proteins allow customers to achieve more efficient use of raw materials, reduce energy consumption, replace traditional chemicals with more sustainable alternatives, and offer higher-quality products.
BioVision aims to provide innovative, high-quality assay kits, recombinant proteins, antibodies, and other research tools to accelerate drug discovery in disease-related areas like cancer, diabetes, obesity, Alzheimer's disease, etc. The company would achieve these goals through a well-defined core strategy and a company culture that fosters integrity, openness, and collaboration, and rewards customer focus, innovation, and ownership.
6. ENMEX
ENMEX GmbH is located in Magdeburg, Sachsen-Anhalt, Germany, and is part of the Architectural, Engineering, and Related Services Industry. ENMEX GmbH has 2 total employees across all of its locations and generates USD 289,000 in sales.
Founded in 1992 and headquartered in London, UK, Bioline is an evolving international company At Bioline, the company constantly strives to improve and deliver high-quality products which are the result of strong commitment and investment in science. Bioline, wholly owned by Meridian Bioscience Inc. (Nasdaq: VIVO), operates as one multi-cultural global team with strong values.
Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. The company is listed as ROG (SWX) in the stock exchange market.
Fapon Biotech Inc., founded in 2001, adheres to the mission of “Enable Disease Identification Earlier, More Accurate, Convenient and Affordable”, while focusing on the future needs and trends of biotechnology development, and is committed to providing global diagnostic companies with high-performance IVD reagent raw materials, such as antigens, antibodies, and enzymes, as well as reagent solutions and innovative open instrument platforms. The company’s products and services are highly integrated, promoting synergic resources and shared values to the industry, making the developments of diagnostic technologies benefit more people, advancing the cause of human health.
Get a Free Sample Here: https://www.vantagemarketresearch.com/industrial-enzymes-market-1358/request-sample
For More Information about each of these companies.
Vantage Market Research Report comes up with a detailed analysis of each major player in the industry. The Study provides Global market size & share, Emerging trends, an in-depth analysis of key players, Development opportunities, Sales, and a Revenue Forecast.
